Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of nalbuphine administration in elderly total knee arthroplasty
ChiCTR2600125391Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in postoperative pain (3 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Postoperative 30-minute VAS pain score. Started May 2026; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600125391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125391.